Trial Profile
A 1-year open-label safety extension study of pregabalin in patients with anxiety disorders
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Anxiety disorders
- Focus Adverse reactions
- Sponsors Pfizer
- 13 Nov 2005 New trial record.